Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations
Sponsor: Cancer League of Colorado
Listed as NCT03958565, this observational or N/A phase trial focuses on Carcinoma, Non-Small-Cell Lung and remains actively recruiting participants. Sponsored by Cancer League of Colorado, it has been updated 15 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
May 2025 — Jun 2025 [monthly]
Recruiting
-
Jan 2025 — May 2025 [monthly]
Recruiting
-
Oct 2024 — Jan 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
▶ Show 10 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Recruiting
-
Apr 2023 — Apr 2024 [monthly]
Recruiting
-
Jun 2022 — Apr 2023 [monthly]
Recruiting
-
Apr 2022 — Jun 2022 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Dec 2020 [monthly]
Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cancer League of Colorado
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .